{
    "title": "Individual feed for https://www.marketbeat.com/feed/",
    "link": "https://www.marketbeat.com/feed/",
    "description": "Individual feed output.",
    "lastBuildDate": "2025-12-24T06:05:57.459770",
    "items": [
        {
            "title": "Darden Restaurants, Inc.: This is What a Strong Signal Looks Like",
            "link": "https://www.marketbeat.com/originals/darden-restaurants-inc-this-is-what-a-strong-signal-looks-like/",
            "description": "Darden Restaurants is positioned for market-beating total returns in 2026 as a technical signal combines with fundamental qualities like dividends and...",
            "pubDate": "2025-12-23T17:05:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png"
        },
        {
            "title": "Amazon Looks Stuck—So Why Do Analysts Keep Calling for $300?",
            "link": "https://www.marketbeat.com/originals/amazon-looks-stuckso-why-do-analysts-keep-calling-for-300/",
            "description": "Amazon stock is stuck in consolidation mode despite multiple $300-plus targets. But tightening price action suggests a breakout might be coming.",
            "pubDate": "2025-12-23T16:46:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png"
        },
        {
            "title": "Carnival’s Dividend Return Marks the End of Survival Mode",
            "link": "https://www.dividendstocks.com/articles/carnivals-dividend-return-marks-the-end-of-survival-mode/",
            "description": "Carnival Corporation has reinstated its dividend following a record year of financial recovery and debt reduction.",
            "pubDate": "2025-12-23T15:12:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        },
        {
            "title": "Why CorMedix Could be the Biopharma Name to Watch Early in 2026",
            "link": "https://www.marketbeat.com/originals/why-cormedix-could-be-the-biopharma-name-to-watch-early-in-2026/",
            "description": "CorMedix is a promising biopharma firm in the catheter lock solution space. Continued success for its top products could fuel significant growth into ...",
            "pubDate": "2025-12-23T14:20:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Cintas’ $5.2B UniFirst Bid Ignites the Battle for Route Dominance",
            "link": "https://www.marketbeat.com/originals/cintas-52b-unifirst-bid-ignites-the-battle-for-route-dominance/",
            "description": "A strategic, multi-billion-dollar proposal seeks to combine two industry leaders to unlock massive operational efficiencies through optimized route de...",
            "pubDate": "2025-12-23T13:34:00",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png"
        }
    ]
}